Sage's Brexanolone Could Be Transformative, But Only In Controlled Settings, US FDA Panel Says

Advisory committee strongly favored approval of postpartum depression therapy, but many members suggest it should be administered in a facility with trained medical staff to avoid potential safety concerns.